Nilstat

   
Google
 
Web NewDrugInformation.com

Nilstat


Drug - Nilstat
The trade name of the product as shown on the labeling.

Dosage - TABLET; VAGINAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Nystatin
Multiple ingredients are in alphabetical order.

Strength - 100,000 UNITS
The potency of the active ingredient(s), Nystatin. May repeat for multiple part products.

Applicant - LEDERLE
The firm name holding legal responsibility for Nilstat. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 061325
The FDA assigned number to Nilstat. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Nilstat. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Nilstat was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Nilstat. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Nilstat is in. Format is RX, OTC, DISCN.

Applicant Full Name - Lederle Laboratories Div American Cyanamid Co
The full name of the firm holding legal responsibility for the new application of Nilstat.

Nilstat